Two Sigma Securities’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,100
Closed -$557K 3243
2023
Q4
$557K Buy
+4,100
New +$500K 0.01% 1474
2022
Q2
Sell
-3,200
Closed -$417K 2503
2022
Q1
$417K Sell
3,200
-3,100
-49% -$404K 0.01% 1144
2021
Q4
$962K Buy
+6,300
New +$975K 0.04% 277
2021
Q3
Sell
-17,500
Closed -$2.86M 1714
2021
Q2
$2.86M Buy
+17,500
New +$2.7M 0.09% 168
2021
Q1
Sell
-14,300
Closed -$2.17M 1241
2020
Q4
$2.17M Buy
14,300
+5,300
+59% +$757K 0.05% 230
2020
Q3
$1.22M Sell
9,000
-4,600
-34% -$624K 0.02% 304
2020
Q2
$1.86M Buy
13,600
+2,300
+20% +$293K 0.04% 244
2020
Q1
$1.22M Sell
11,300
-101,600
-90% -$11.7M 0.03% 347
2019
Q4
$13.6M Buy
112,900
+63,600
+129% +$7.1M 0.09% 156
2019
Q3
$4.91M Buy
49,300
+5,900
+14% +$618K 0.04% 322
2019
Q2
$4.74M Sell
43,400
-32,700
-43% -$3.48M 0.05% 250
2019
Q1
$8.51M Sell
76,100
-41,600
-35% -$4.56M 0.08% 111
2018
Q4
$11.3M Buy
117,700
+40,400
+52% +$4.29M 0.14% 78
2018
Q3
$9.43M Sell
77,300
-103,600
-57% -$12.2M 0.06% 221
2018
Q2
$19.9M Buy
180,900
+42,700
+31% +$4.57M 0.1% 153
2018
Q1
$14.8M Buy
138,200
+129,600
+1,507% +$14.4M 0.08% 207
2017
Q4
$918K Buy
+8,600
New +$919K 0.02% 447

Other funds holding IBB

Two Sigma Securities's IBB Position: Q1 2026 in Review

Two Sigma Securities sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 3,373 shares — an estimated $569K sold.

Two Sigma Securities first reported a position in IBB in Q1 2015 and held it in 28 quarters. The position peaked at $12.4M in Q1 2017. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Two Sigma Securities reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 3,373 iShares Biotechnology ETF shares in Q1 2026, an estimated $569K.
  • Two Sigma Securities first reported a position in iShares Biotechnology ETF in Q1 2015 and held it in 28 quarters.
  • Two Sigma Securities's iShares Biotechnology ETF position peaked at $12.4M in Q1 2017.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.